News We’re Watching: Activist Investor Causes Kerfuffle At Nevro, Lifespin Launches Antibiotic Dx, And More

 
• By Reed Miller
  
Industry News We're Watching
• Source: Shutterstock

More from Clinical Trials

More from R&D